Schizophrenia and Bipolar Disorder: Improving Adherence and New Therapeutic Updates
Manage episode 358838968 series 3381434
Thông tin tác giả ReachMD được phát hiện bởi Player FM và cộng đồng của chúng tôi - bản quyền thuộc sở hữu của nhà sản xuất (publisher), không thuộc về Player FM, và audio được phát trực tiếp từ máy chủ của họ. Bạn chỉ cần nhấn nút Theo dõi (Subscribe) để nhận thông tin cập nhật từ Player FM, hoặc dán URL feed vào các ứng dụng podcast khác.
CME credits: 0.50
Valid until: 22-03-2024
Claim your CME credit at https://reachmd.com/programs/cme/schizophrenia-and-bipolar-disorder-improving-adherence-and-new-therapeutic-updates/14991/
Schizophrenia affects an estimated 21 million people worldwide, and bipolar disorder (BPD) is the sixth leading cause of disability. These are chronic psychiatric illnesses that require long-term care, and place significant health and economic burdens on patients and their families. In recent decades, the distinct separation of these two illnesses has weakened, and the medical literature now recognizes a partial genetic overlap between schizophrenia and BPD. Unfortunately, both schizophrenia and BPD are difficult to treat and are associated with substantial morbidity and mortality, particularly when sub-optimally treated. Lack of consistent adherence to treatment is a significant issue; however, newer formulations have recently been approved and emerging therapies are on the horizon.=
…
continue reading
Valid until: 22-03-2024
Claim your CME credit at https://reachmd.com/programs/cme/schizophrenia-and-bipolar-disorder-improving-adherence-and-new-therapeutic-updates/14991/
Schizophrenia affects an estimated 21 million people worldwide, and bipolar disorder (BPD) is the sixth leading cause of disability. These are chronic psychiatric illnesses that require long-term care, and place significant health and economic burdens on patients and their families. In recent decades, the distinct separation of these two illnesses has weakened, and the medical literature now recognizes a partial genetic overlap between schizophrenia and BPD. Unfortunately, both schizophrenia and BPD are difficult to treat and are associated with substantial morbidity and mortality, particularly when sub-optimally treated. Lack of consistent adherence to treatment is a significant issue; however, newer formulations have recently been approved and emerging therapies are on the horizon.=
983 tập
Chia sẻ
))
